Neurocrine Biosciences Inc NBIX
NBIX among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
NBIX and 9 peers, year by year
The 9 Health care companies closest to NBIX in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences Inc | FY2025 | $2.9B | +21.4% | - | 21.6% | 16.7% | 26.2% | 14.7% | - |
| BMRN Biomarin Pharmaceutical Inc | FY2025 | $3.2B | +12.9% | - | 12.7% | 10.8% | 22.5% | 5.7% | 0.10 |
| XRAY DENTSPLY SIRONA Inc. | FY2025 | $3.7B | −3.0% | 50.0% | −11.5% | −16.2% | 2.8% | −44.7% | 1.76 |
| VEEV Veeva Systems | FY2026 | $3.2B | +16.3% | 75.5% | 28.7% | 28.4% | - | 12.6% | - |
| CRL Charles River Laboratories | FY2025 | $4.0B | −0.9% | - | 0.6% | −3.6% | 12.9% | −4.6% | 0.68 |
| ACHC Acadia Healthcare Company, Inc. | FY2025 | $3.3B | +5.0% | - | - | −33.3% | −13.3% | −56.6% | 1.28 |
| WST West Pharmaceutical Services | FY2025 | $3.1B | +6.3% | 35.9% | 19.0% | 16.1% | 15.3% | 15.5% | 0.06 |
| SGRY Surgery Partners, Inc. | FY2025 | $3.3B | +6.2% | - | 11.8% | −2.4% | 5.9% | −4.5% | 2.18 |
| PRGO PERRIGO Co plc | FY2025 | $4.3B | −2.8% | 35.1% | −26.4% | −33.5% | 3.4% | −48.6% | 1.24 |
| ALGN Align Technology | FY2025 | $4.0B | +0.9% | 67.2% | 13.5% | 10.2% | 12.2% | 10.1% | - |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2016 to FY2025
Revenue as reported in the 10-K.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | $15.0M | $161.6M | $451.2M | $788.1M | $1.0B | $1.1B | $1.5B | $1.9B | $2.4B | $2.9B |
| BMRN Dec | $1.1B | $1.3B | $1.5B | $1.7B | $1.9B | $1.8B | $2.1B | $2.4B | $2.9B | $3.2B |
| XRAY Dec | $3.7B | $4.0B | $4.0B | $4.0B | $3.3B | $4.2B | $3.9B | $4.0B | $3.8B | $3.7B |
| VEEV Jan | $409.2M | $550.5M | $690.6M | $862.2M | $1.1B | $1.5B | $1.9B | $2.2B | $2.4B | $2.7B |
| CRL Dec | $1.7B | $1.9B | $2.3B | $2.6B | $2.9B | $3.5B | $4.0B | $4.1B | $4.0B | $4.0B |
| ACHC Dec | $2.8B | $2.8B | $1.9B | $2.0B | $2.1B | $2.3B | $2.6B | $2.9B | $3.2B | $3.3B |
| WST Dec | $1.5B | $1.6B | $1.7B | $1.8B | $2.1B | $2.8B | $2.9B | $2.9B | $2.9B | $3.1B |
| SGRY Dec | $1.1B | - | $1.8B | $1.8B | $1.9B | $2.2B | $2.5B | $2.7B | $3.1B | $3.3B |
| PRGO Dec | $5.3B | $4.9B | $4.7B | $3.9B | $4.1B | $4.1B | $4.5B | $4.7B | $4.4B | $4.3B |
| ALGN Dec | $1.1B | $1.5B | $2.0B | $2.4B | $2.5B | $4.0B | $3.7B | $3.9B | $4.0B | $4.0B |
| Peer median | $1.5B | $1.7B | $1.9B | $2.0B | $2.1B | $2.8B | $2.9B | $2.9B | $3.2B | $3.3B |
Sales growth, FY2016 to FY2025
Revenue against the fiscal year before.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | −24.1% | +978% | +179% | +74.7% | +32.7% | +8.4% | +31.3% | +26.8% | +24.8% | +21.4% |
| BMRN Dec | +25.5% | +17.6% | +13.5% | +14.3% | +9.2% | −0.8% | +13.5% | +15.4% | +18.0% | +12.9% |
| XRAY Dec | +40.0% | +6.6% | −0.2% | +1.1% | −17.0% | +26.7% | −7.3% | +1.1% | −4.3% | −3.0% |
| VEEV Jan | - | +32.9% | +25.4% | +24.9% | +28.1% | +32.7% | +26.3% | +16.4% | +9.7% | +16.2% |
| CRL Dec | +23.3% | +10.5% | +22.0% | +15.7% | +11.5% | +21.1% | +12.3% | +3.9% | −1.9% | −0.9% |
| ACHC Dec | - | +0.9% | +6.2% | +5.4% | +4.1% | +10.7% | +12.8% | +12.2% | +7.7% | +5.0% |
| WST Dec | +7.8% | +6.0% | +7.4% | +7.1% | +16.7% | +31.9% | +2.0% | +2.2% | −1.9% | +6.3% |
| SGRY Dec | +19.3% | - | - | +3.4% | +1.6% | +19.6% | +14.1% | +8.0% | +13.5% | +6.2% |
| PRGO Dec | - | −6.3% | −4.3% | +2.2% | +5.6% | +1.2% | +7.6% | +4.6% | −6.1% | −2.8% |
| ALGN Dec | +27.7% | +36.4% | +33.5% | +22.4% | +2.7% | +59.9% | −5.5% | +3.4% | +3.5% | +0.9% |
| Peer median | +24.4% | +8.6% | +10.5% | +7.1% | +5.6% | +21.1% | +12.3% | +4.6% | +3.5% | +5.0% |
Gross margin, FY2016 to FY2025
Gross profit / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | - | - | - | - | - | - | - | - | - | - |
| BMRN Dec | - | - | - | - | - | - | - | - | - | - |
| XRAY Dec | 53.4% | 54.8% | 51.9% | 53.8% | 49.6% | 55.5% | 54.2% | 52.6% | 51.6% | 50.0% |
| VEEV Jan | 65.2% | 68.5% | 69.4% | 71.6% | 72.5% | 72.1% | 72.8% | 71.7% | 71.3% | 74.5% |
| CRL Dec | - | - | - | - | - | - | - | - | - | - |
| ACHC Dec | - | - | - | - | - | - | - | - | - | - |
| WST Dec | 33.2% | 32.1% | 31.8% | 32.9% | 35.8% | 41.5% | 39.4% | 38.3% | 34.5% | 35.9% |
| SGRY Dec | - | - | - | - | - | - | - | - | - | - |
| PRGO Dec | 38.9% | 40.0% | 38.7% | 37.0% | 36.6% | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| ALGN Dec | 75.5% | 75.8% | 73.6% | 72.5% | 71.3% | 74.3% | 70.5% | 70.1% | 70.0% | 67.2% |
| Peer median | 53.4% | 54.8% | 51.9% | 53.8% | 49.6% | 55.5% | 54.2% | 52.6% | 51.6% | 50.0% |
Operating margin, FY2016 to FY2025
Operating income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | −982.5% | −81.3% | 8.2% | 9.2% | 15.6% | 9.0% | 16.7% | 13.3% | 24.2% | 21.6% |
| BMRN Dec | −71.9% | −1.1% | −8.3% | −5.9% | −2.3% | −4.5% | 7.7% | 7.7% | 17.0% | 12.7% |
| XRAY Dec | 12.1% | −39.1% | −24.0% | 8.8% | −0.1% | 14.4% | −23.9% | −2.1% | −23.2% | −11.5% |
| VEEV Jan | 19.2% | 21.9% | 22.9% | 25.8% | 25.9% | 25.8% | 27.3% | 21.3% | 18.2% | 25.2% |
| CRL Dec | 14.1% | 15.5% | 14.6% | 13.4% | 14.8% | 16.7% | 16.4% | 14.9% | 5.6% | 0.6% |
| ACHC Dec | 21.7% | 21.3% | 31.2% | 29.2% | - | - | - | - | - | - |
| WST Dec | 12.9% | 14.1% | 14.0% | 16.1% | 19.0% | 26.6% | 25.4% | 22.9% | 19.7% | 19.0% |
| SGRY Dec | 17.2% | - | 4.4% | 12.9% | 9.8% | 13.6% | 13.6% | 12.0% | 11.2% | 11.8% |
| PRGO Dec | −37.9% | 12.1% | 5.0% | 4.5% | 6.5% | 9.9% | 1.8% | 3.3% | 2.6% | −26.4% |
| ALGN Dec | 23.1% | 24.0% | 23.7% | 22.5% | 15.7% | 24.7% | 17.2% | 16.7% | 15.2% | 13.5% |
| Peer median | 14.1% | 14.8% | 14.0% | 13.4% | 12.3% | 15.5% | 15.0% | 13.5% | 13.2% | 12.2% |
Net margin, FY2016 to FY2025
Net income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | −940.6% | −88.2% | 4.7% | 4.7% | 38.9% | 7.9% | 10.4% | 13.2% | 14.5% | 16.7% |
| BMRN Dec | −56.4% | −8.9% | −5.2% | −1.4% | 45.9% | −3.5% | 6.8% | 6.9% | 15.0% | 10.8% |
| XRAY Dec | 11.5% | −38.8% | −25.4% | 6.4% | −2.2% | 9.7% | −24.2% | −3.3% | −24.0% | −16.2% |
| VEEV Jan | 13.3% | 14.1% | 21.9% | 26.7% | 27.3% | 25.9% | 23.1% | 22.6% | 22.2% | 26.0% |
| CRL Dec | 9.2% | 6.6% | 10.0% | 9.6% | 12.5% | 11.0% | 12.2% | 11.5% | 0.5% | −3.6% |
| ACHC Dec | 0.2% | 7.0% | −9.2% | 5.4% | −32.2% | 8.2% | 10.5% | −0.7% | 8.1% | −33.3% |
| WST Dec | 9.5% | 9.4% | 12.0% | 13.1% | 16.1% | 23.4% | 20.3% | 20.1% | 17.0% | 16.1% |
| SGRY Dec | 0.8% | - | −11.6% | −4.1% | −6.2% | −3.2% | −2.2% | −0.4% | −5.4% | −2.4% |
| PRGO Dec | −76.0% | 2.4% | 2.8% | 3.8% | −4.0% | −1.7% | −3.2% | −0.3% | −3.9% | −33.5% |
| ALGN Dec | 17.6% | 15.7% | 20.4% | 18.4% | 71.8% | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% |
| Peer median | 9.2% | 6.8% | 2.8% | 6.4% | 12.5% | 9.7% | 9.7% | 6.9% | 8.1% | −2.4% |
Free cash flow, FY2016 to FY2025
Cash from operations minus capital spending.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | −$110.3M | −$101.3M | $76.6M | $132.3M | $217.6M | $233.1M | $322.9M | $361.6M | $557.2M | $748.7M |
| BMRN Dec | −$376.2M | −$208.0M | −$124.4M | −$96.8M | −$28.9M | $209.0M | $54.9M | $62.6M | $487.4M | $725.0M |
| XRAY Dec | $438.4M | $457.6M | $317.0M | $516.0M | $562.0M | $515.0M | $368.0M | $228.0M | $281.0M | $104.0M |
| VEEV Jan | $59.0M | $137.1M | $223.8M | $302.4M | $434.3M | - | - | - | - | - |
| CRL Dec | $261.6M | $235.6M | $301.1M | $340.4M | $380.0M | $532.0M | $294.9M | $365.4M | $501.6M | $518.5M |
| ACHC Dec | $54.0M | $125.4M | $160.9M | $100.2M | $433.8M | $129.7M | $84.4M | $38.2M | −$560.7M | −$439.9M |
| WST Dec | $49.2M | $132.5M | $183.9M | $240.8M | $298.1M | $330.6M | $439.4M | $414.5M | $276.4M | $468.9M |
| SGRY Dec | $86.1M | - | $104.8M | $55.9M | $204.0M | $29.5M | $78.2M | $205.0M | $209.7M | $195.6M |
| PRGO Dec | $548.7M | $610.3M | $490.4M | $250.1M | $465.8M | $4.2M | $210.9M | $303.8M | $244.6M | $145.1M |
| ALGN Dec | $177.1M | $242.8M | $331.4M | $597.6M | $507.3M | $771.4M | $276.8M | $608.1M | $622.7M | $490.8M |
| Peer median | $86.1M | $186.4M | $223.8M | $250.1M | $433.8M | $269.8M | $243.9M | $265.9M | $278.7M | $332.2M |
FCF margin, FY2016 to FY2025
Free cash flow / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | −735.3% | −62.7% | 17.0% | 16.8% | 20.8% | 20.6% | 21.7% | 19.2% | 23.7% | 26.2% |
| BMRN Dec | −33.7% | −15.8% | −8.3% | −5.7% | −1.6% | 11.3% | 2.6% | 2.6% | 17.1% | 22.5% |
| XRAY Dec | 11.7% | 11.5% | 8.0% | 12.8% | 16.8% | 12.2% | 9.4% | 5.8% | 7.4% | 2.8% |
| VEEV Jan | 14.4% | 24.9% | 32.4% | 35.1% | 39.3% | - | - | - | - | - |
| CRL Dec | 15.6% | 12.7% | 13.3% | 13.0% | 13.0% | 15.0% | 7.4% | 8.8% | 12.4% | 12.9% |
| ACHC Dec | 1.9% | 4.4% | 8.4% | 5.0% | 20.8% | 5.6% | 3.2% | 1.3% | −17.8% | −13.3% |
| WST Dec | 3.3% | 8.3% | 10.7% | 13.1% | 13.9% | 11.7% | 15.2% | 14.1% | 9.6% | 15.3% |
| SGRY Dec | 7.5% | - | 5.9% | 3.1% | 11.0% | 1.3% | 3.1% | 7.5% | 6.7% | 5.9% |
| PRGO Dec | 10.4% | 12.3% | 10.4% | 6.5% | 11.4% | 0.1% | 4.7% | 6.5% | 5.6% | 3.4% |
| ALGN Dec | 16.4% | 16.5% | 16.9% | 24.8% | 20.5% | 19.5% | 7.4% | 15.7% | 15.6% | 12.2% |
| Peer median | 10.4% | 11.9% | 10.4% | 12.8% | 13.9% | 11.5% | 6.1% | 7.0% | 8.5% | 9.0% |
Return on equity, FY2016 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | −44.8% | −38.3% | 4.4% | 5.8% | 36.2% | 6.5% | 9.0% | 11.2% | 13.2% | 14.7% |
| BMRN Dec | −22.8% | −4.2% | −2.6% | −0.8% | 20.8% | −1.5% | 3.1% | 3.4% | 7.5% | 5.7% |
| XRAY Dec | 5.3% | −23.4% | −19.7% | 5.0% | −1.5% | 8.2% | −24.9% | −4.0% | −46.9% | −44.7% |
| VEEV Jan | 10.4% | 11.4% | 16.7% | 18.6% | 18.1% | 16.8% | 14.7% | 13.1% | 11.3% | 12.2% |
| CRL Dec | 18.5% | 11.8% | 17.2% | 15.4% | 17.2% | 15.4% | 16.3% | 13.2% | 0.6% | −4.6% |
| ACHC Dec | 0.3% | 7.8% | −7.5% | 4.3% | −35.4% | 7.6% | 9.7% | −0.8% | 8.3% | −56.6% |
| WST Dec | 12.9% | 11.8% | 14.8% | 15.4% | 18.7% | 28.3% | 21.8% | 20.6% | 18.4% | 15.5% |
| SGRY Dec | 97.7% | - | −50.8% | −25.2% | −100.4% | −6.5% | −2.7% | −0.6% | −9.4% | −4.5% |
| PRGO Dec | −67.4% | 1.9% | 2.3% | 2.5% | −2.9% | −1.3% | −2.9% | −0.3% | −4.0% | −48.6% |
| ALGN Dec | 19.0% | 20.0% | 31.9% | 32.9% | 54.9% | 21.3% | 10.0% | 12.3% | 10.9% | 10.1% |
| Peer median | 10.4% | 9.6% | 2.3% | 5.0% | 17.2% | 8.2% | 9.7% | 3.4% | 7.5% | −4.5% |
Debt / equity, FY2016 to FY2025
Total debt / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | - | - | - | - | - | - | - | - | - | - |
| BMRN Dec | - | - | - | - | - | - | - | - | - | 0.10 |
| XRAY Dec | 0.19 | 0.25 | 0.32 | 0.28 | 0.46 | 0.42 | 0.52 | 0.65 | 1.12 | 1.76 |
| VEEV Jan | - | - | - | - | - | - | - | - | - | - |
| CRL Dec | 1.41 | 1.04 | 1.22 | 1.15 | 0.93 | 1.05 | 0.91 | 0.74 | 0.65 | 0.68 |
| ACHC Dec | 1.52 | 1.26 | 1.37 | 1.26 | 1.64 | 0.59 | 0.49 | 0.49 | 0.64 | 1.28 |
| WST Dec | 0.21 | 0.15 | 0.14 | 0.16 | 0.14 | 0.11 | 0.08 | 0.07 | 0.08 | 0.06 |
| SGRY Dec | n/m | - | 5.75 | 8.75 | n/m | 2.72 | 1.32 | 1.41 | 1.90 | 2.18 |
| PRGO Dec | 0.97 | 0.54 | 0.57 | 0.58 | 0.63 | 0.68 | 0.85 | 0.85 | 0.84 | 1.24 |
| ALGN Dec | - | - | - | - | - | - | - | - | - | - |
| Peer median | 0.97 | 0.54 | 0.90 | 0.87 | 0.63 | 0.64 | 0.68 | 0.70 | 0.74 | 1.24 |
EPS (diluted), FY2016 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| NBIX Dec | −$1.63 | −$1.62 | $0.22 | $0.39 | $4.16 | $0.92 | $1.56 | $2.47 | $3.29 | $4.67 |
| BMRN Dec | −$3.81 | −$0.67 | −$0.44 | −$0.13 | $4.50 | −$0.35 | $0.75 | $0.87 | $2.21 | $1.80 |
| XRAY Dec | $1.94 | −$6.76 | −$4.51 | $1.14 | −$0.33 | $1.87 | −$4.41 | −$0.62 | −$4.48 | −$3.00 |
| VEEV Jan | $0.38 | $0.53 | $0.98 | $1.47 | $1.90 | $2.36 | $2.63 | $3.00 | $3.22 | $4.32 |
| CRL Dec | $3.23 | $2.54 | $4.62 | $5.07 | $7.20 | $7.60 | $9.48 | $9.22 | $0.20 | −$2.91 |
| ACHC Dec | $0.07 | $2.30 | −$2.01 | $1.24 | −$7.59 | $2.10 | $2.98 | −$0.24 | $2.78 | −$12.16 |
| WST Dec | $1.91 | $1.99 | $2.74 | $3.21 | $4.57 | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
| SGRY Dec | $0.20 | - | −$4.96 | −$2.29 | −$3.19 | −$1.12 | −$0.59 | −$0.09 | −$1.33 | −$0.61 |
| PRGO Dec | −$28.01 | $0.84 | $0.95 | $1.07 | −$1.19 | −$0.52 | −$1.04 | −$0.09 | −$1.25 | −$10.29 |
| ALGN Dec | $2.33 | $2.83 | $4.92 | $5.53 | $22.41 | $9.69 | $4.61 | $5.81 | $5.62 | $5.65 |
| Peer median | $0.38 | $1.42 | $0.95 | $1.24 | $1.90 | $2.10 | $2.63 | $0.87 | $2.21 | −$0.61 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out NBIX and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: NBIX's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NBIX/export.csv") into a cell.